Gaurav Chandra
Gaurav Chandra
Contributor, The Yuan

Gaurav Chandra is the Chief Operating Officer of Enzolytics, a drug development company. He also runs a platform that uses AI to assess the effects of nutrition, genetics and gut microbiome on chronic medical diseases and infectious diseases. He is a strong proponent of AI's role in early drug discovery and development.

Demystifying the Human Microbiome Using AI
Optimization
Artificial Intelligence continues to be a significant driver for advancing healthcare and understanding the microbiome will be pivotal to that transformation. Dr Gaurav Chandra discusses the crucial role the microbiome will play, enabling precision medicine that is more preventive, predictive, and personal than ever before.
Gaurav Chandra  |  Dec 01, 2021